Chawla Medicos
Karol Bagh, Delhi
SEND SMS
SEND EMAIL
Product Details:
| Minimum Order Quantity | 1 Box |
| Brand | Dr. Reddy |
| Dose/Strength | 60mg |
| Packaging Size | 1X28 |
| Packaging Type | Tablets |
| Composition | Daclatasvir tablets |
| Indications | Hepatitis c Treament |
| Type of Medicines | Life saving Drug |
| Grade standard | Medicine Grade |
| Form Of Medicines | Tablets |
| Dose | 60mg |
| Age (Year) | Adult |
| API Form | tablet |
| Medicine Type | Life Saving Drug |
| Size | 1X28 |
Additional Information:
Product Details:
| Minimum Order Quantity | 1 Bottle |
| Brand | Resof By Dr. Reddy, Resof By Dr. Reddy |
| Dosage Form | Tablet |
| Dose/Strength | 400mg, 400mg |
| Packaging Size | 1X28, 1X28 |
| Packaging Type | Strip, Strip |
| Composition | Sofosbuvir Tablets , Sofosbuvir Tablets |
| Indications | Hepatitis c Treatment , Hepatitis c Treatment |
Additional Information:
Product Details:
| Minimum Order Quantity | 1 Bottle |
| Brand | Dalsiclear |
| Dose/Strength | Daclatasvir 60mg |
| Packaging Size | 1X28 |
| Packaging Type | Bottle |
| Composition | Daclatasvir |
| Indications | The Heaptitis Treatment Drug |
Marketed By: "Abbott" ;
Indian Brand - "Dalsiclear" ;
Active Ingredient(s) - "Daclatasvir" ;
Strength - "60mg" ;
Dosage Form - "Tablet" ;
Package Size - "28 Tabs" ;
Package Type - "Plastic Bottle" ;
Expiry - "1 Year to 2 Years" ;
Indication(s) - "Hepatitis C Virus (HCV) Infection" ;
UPC / GTIN Barcode - "No" ;
Prescription Required - "Yes" ;
"The Hepatitis C Treatment Drug"
Dalsiclear 60mg Tablet is used in the treatment of chronic hepatitis C virus (HCV) infection.
Chronic hepatitis C infection can cause serious liver problems such as scarring (cirrhosis), or liver cancer.
Each Tablet Of Dalsiclear Contains 60mg Of Daclatasvir. In One Bottle There Is 28 Tabltes
Common Side Effects:The dosage should be determined by the doctor based on your age, overall medical history and current condition. The usual dose in adults for treating chronic hepatitis C is 60 mg, taken orally once daily for a period of 12 weeks.
We are the reliable organization engaged in offering high quality and well-tested Dalsiclear Tablets. The offered tablets are appreciated for their purity, effectiveness and long shelf life. Our provided tablets are processed using optimum quality chemical compounds and ultra-modern technology in compliance with industry norms. Apart from this, these tablets are checked by quality analyst against various parameters so as to ensure their quality.
Additional Information:
Product Details:
| Minimum Order Quantity | 1 Bottle |
| Brand | Sofocure V |
| Composition | Velpatasvir and sofosbuvir |
| Indications | The Hepatitis c Treatment Durg |
| Dosage Form | Tablet |
| Dose/Strength | Velpatasvir 100mg And Sofosbuvir 400mg |
| Packaging Size | 28 tablets |
| Packaging Type | bottle |
| Uses | The Hepatitis C Treatment Drug |
Marketed By: "Emcure " ;
Indian Brand - "Sofocure V" ;
Active Ingredient(s) - "Velpatasvir And Sofosbuvir" ;
Strength - "100mg and 400mg" ;
Dosage Form - "Tablets" ;
Package Type - "Bottle" ;
Package Size - "28Tablets" ;
Expiry - "1 Year to 2 Years" ;
Indication(s) - "Used In The Treatment Of Hepatitis C." ;
Velpatasvir & Sofosbuvir (Tablet Sofocure V) by Hetero is a combination of sofosbuvir and velpatasvir and is used to treat chronic (long-lasting) hepatitis C, a viral infection of the liver. It is also used with another antiviral medication (ribavirin). These drugs work by reducing the amount of hepatitis C virus in your body, which helps your immune system fight the infection and may help your liver recover.
Chronic hepatitis C infection can cause serious liver problems such as scarring (cirrhosis), or liver cancer.
How to Buy Online from IndiaChawla Medicos is a leading supplier of in India that provides quality medicines around the world with affordable prices. Our objective is to help people that are suffering from Hepatitis C and other serious life threatening diseases across the world in procuring Indian medicines which are trusted by doctors. We work with doctors in many hospitals, medical practitioners, and institutions.
Additional Information:
Product Details:
| Minimum Order Quantity | 1 Box |
| Brand | Zydus |
| Dosage Form | Tablet |
| Dose/Strength | 90mg and 400mg |
| Packaging Size | 1X28 Tablets |
| Packaging Type | Box |
| Composition | Ledipasvir and sofosbuvir |
| Indications | Hepatitis c |
| Application | Cure Hepatitis C Virus |
| Type Of Medicines | Life Saving Drug |
| Dose | 90mg and 400mg |
| Medicine Type | Life Saving Drug |
We have been able to build up a long and mutual business relationship with clients by offering Ledihep Ledipasvir and Sofosbuvir Tablets. Our diloigent agents procure Ledihep tablets from the most authentic vendors of the market. The tablets are highly effective for the treatment of chronic hepatitis C (CHC) genotype 1 infection in adults. Clients can avail Ledihep tablets from us in different quantity packaging options. We offer Ledihep Ledipasvir and Sofosbuvir Tablets at affordable prices.
Features:
Product Description
Ledihep is a fixed-dose combination tablet containing ledipasvir and sofosbuvir for oral administration.Each film, coated tablet contains 90 mg ledipasvir and 400 mg sofosbuvir.
INDICATIONS AND USAGE
LediHep is indicated for the treatment of choronic hepatitis C (CHC) genotype 1 infection in adults.
DOSAGES AND ADMINISTRATION
Recommended Dosage in Adults
Ledihep is two-drug fixed-dose combination product that contained 90 mg of ledipasvir and 400 mg of sofosbuvir in a single tablet.The recommended dosages of LediHep is one tablet taken orally once daily with or without food.
Duration of treatment
Relapse rates are affected by baseline host and viral factors and differ between treatment durations for certain subgroups. Below provides the recommended LediHep treatment durations for treatment-naive and treatment-experienced patients and those with and without cirrhosis.
Recommended Treatment Duration for LediHep in Patients with CHC Genotype 1
WARNING: Ledihep is a prescription drug and should be used under proper medical guidance and advice.The information provided here is for Ledihep is a prescription drug and should be used under proper medical guidance and advice.The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers. Ledihep is a prescription drug and should be used under proper medical guidance and advice.
Additional Information:
Product Details:
| Minimum Order Quantity | 1 Bottle |
| Brand | Sovihep Tablets |
| Dosage Form | Tablet |
| Dose/Strength | Sofosbuvir 400mg |
| Packaging Size | 28 Tablets |
| Packaging Type | Box |
| Composition | Sofosbuvir Tablets |
| Indications | Hepatitis C Treatment |
Product Description
These tablets should be used combination with ribavirin or in combination with pegylated interferon. We have been able to attain strong market goodwill as a trusted organization engaged in offering our clients Sovihep Sofosbuvir 400mg Tablets. These tablets are indicated in combination with other medical products for the treatment of chronic hepatitis C in adults. We source these tablets from the trusted and reliable vendors of the market. We offer these Sofosbuvir 400mg Tablets at reasonable prices to clients.
Features:
Zydus Sofosbuvir Tablets SoviHep
Product Description
SoviHep tablets are administered orally. Each tablet contains 400 mg.
INDICATIONS AND USAGE
SoviHep is indicated in combination with other medical products for the treatment of chronic hepatitis C (CHC) in adults.
DOSAGES AND ADMINISTRATION
Recommended Dose in adults
The recommended dose of tablets is one 400 mg tablet, taken orally, once daily with or without food SoviHep should be used combination with ribavirin or in combination with pegylated interferon and ribavirin for the treatment of CHC in adults.The recommended regimen and treatment duration for the combination therapy is provided in following table.
Dose Modification
Dose reduction of SoviHep is not recommended.
Genotype 1 and 4:
If a patients has a serious adverse reaction potentially related to peginterferon alfa and /or ribavirin, the peginterferon alfa and/or ribavirin dose should be reduced or discontinued. Refer to the peginterferon alfa and ribavirin prescribing information for the additional information about how to reduce and/or discontinue the peginterferon alfa and/or ribavirin dose.
Genotype 2 and 3:
If a patient has a serious adverse reaction potentially related to ribavirin, the ribavirin dose should be modified or discontinued, if appropriate, until the adverse reaction abates or decreases in sverity.Provides guidelines for dose modifications and discontinuation based on the patient’s hemoglobin concentration and cardiac status.
DOSAGES FORMS AND STRENGTHS
Each film coated tablet of SoviHep 400 mg is available as capsules shaped, brick red colored and debossed with 400 on one side and plain on another side.
CONTRAINDICATIONS
It is used in combination with ribavirin to peginterferon alfa/ribavirin; the contraindications applicable to those agents are applicable to combination therapies. Refer to the prescribing information of peginterferon alfa and ribavirin for a list of their contraindications.
WARNINGS AND PRECAUTIONS
Pregnancy: Use with Ribavirin or Peginterferon Alfa/Ribavirin
Ribavirin may cause birth defects and /or deaths of the exposed fetus and animal have shown that interferons have abortifacient effects. Extreme care must be taken to avoid pregnancy in female patients and in female partners of male patients. Ribavirin therapy should not be started unless a report of a negative pregnancy test has been obtained immediately prior to initiation of therapy.
When this is used in combinations with ribavirin or peginterferon alfa/ribavirin, women of childbearing potential and their male partners must use two forms of effective contraception during treatment and for at least 6 months after treatment. Monthly pregnancy tests must be performed during this time.
Additional Information:
Product Details:
| Minimum Order Quantity | 1 Bottle |
| Brand | Natdac Tablets |
| Dose/Strength | 30mg And 60 Mg |
| Packaging Size | 1X28 |
| Packaging Type | Tablets |
| Composition | Sofosbuvir |
| Indications | Hepatitis c Treament |
We are identified as one of the leading organizations, engaged in offering Natdac Tablets. Our expert agents procure these tablets from the certified vendors of the market. The tablets are indicated in combination with sofosbuvir for the treatment of patient with chronic hepatitis C virus. Natdac Daclatasvir Tablets are recommended to be taken orally with or without meals. We offer these tablets at pocket friendly prices.
Features:
Natdac 60 is an inhibitor of non-structural protein 5A (NS5A).
Each film-coated tablet contains Daclatasvir equivalent to Daclatasvir 30 mg or 60 mg.
INDICATIONS AND USAGE
Natdac 60 is indicated in combination with Sofosbuvir for the treatment of patient with chronic hepatitis C virus (HCV) genotype 3 infection.
DOSAGE AND ADMINISTRATION
Treatment with Natdac 60 should be initiated and monitored by physician experienced in the management of chronic hepatitis C. The recommended dose of Natdac 60 is 60 mg once daily to be taken orally with or without meals. MyDacla 60 must be administered in combination with other medical products.The Packeges inserts of the medicinal products in the regimen should also be consulated before initiation of therapy with Natdac 60. Recommended reginmens and treatment duration are provided below.
Dose modification, interruption and discontinuation
Dose modification of Natdac 60 to manage adverse reactions is not recommended.There is no virologic treatment stopping rules that apply to the combination of Natdac 60 with sofosbuvir.
CONTRAINDICATIONS
Hypersensitivity to the active substance or to any of the excipients Coadministration with medicinal products that strongly induce cytochrome P450 3A4 (CYP3A4) and P-glycoprotein transporter (P-gp) and thus may lead to lower exposure and loss of efficacy of Daclatasvir. These active substances include but are not limited to phenytoin, carbamazepine, oxcarbazepine, rifampicin, rifapentine, systemic dexamethasone, and the herbal product St John’s wort (Hypericum perforatum).
WARNINGS AND PRECAUTIONS
Natdac 60 must not be administered as monotherapy.DeciHeptm must be administered in combination with other medicinal products for the the treatment of chronic HCV infection.
General
The safety and efficacy of the combination of Daclatasvir and sofosbuvir have been evaluated in a limited number of patients with cirrhosis in clinical studies.
Decompensates liver disease
The safety and efficacy of MyDacla 60 in the treatment of HCV infection in patients with decompensated liver disease have not been established.
Retreatment with MyDacla 60
The efficacy of MyDacla 60 as part of a retreatment regimen in patients with prior exposure to a NS5A inhibitor has not been established.
Pregnancy and contraception requirements
Natdac 60 should not be used during pregnancy or in women of childbearing potential not using contraception.Use of highly effective contraception should be continued for 5 weeks after completion of Daclatasvir therapy.
Additional Information:
Product Details:
| Minimum Order Quantity | 1 Piece |
| Dosage Form | Tablet |
| Brand | Ledifos Tablets By Hetero |
| Dose/Strength | Ledipasvir 90 mg And Sofosbuvir 400mg |
| Packaging Size | 1X28 |
| Packaging Type | Bottle |
| Composition | Ledipasvir and sofosbuvir |
| Indications | hepatitis c treatment |
Product Description
Uses
Ledifos tablets contains a combination of two different drugs used to treat chronic hepatitis C virus (HCV). Each tablet contains 90mg of Ledipasvir and 400mg of Sofosbuvir. Together, these drugs act as a potent antiviral agent that treat HCV by interfering with the further replication of the hepatitis C virus (HCV). Ledifos is indicated in the treatment of patients with genotype 1 HCV (the most common HCV subtype in the US and the UK).
Dosage and Administration
Ledifos tablets comes in a pack of 28 tablets. Each table will contain Ledipasvir 90mg/Sofosbuvir 400mg as active ingredients.
Swallowed each tablet whole with a glass of water.
Your doctor will have prescribed a particular dosage for you. Follow this dosage exactly. Continue taking Ledifos for as long as you are advised by your doctor.
Side effects
Ledifos has very few sid effects and the majority are mild and will pass with time.
Some people will experience headaches and/or tiredness when taking Ledifos tablets.
If you develop any signes of an allergic reaction to Ledifos (rash, hives, excessive itching, unusual difficulty breathing, tightness in your chest, or swelling of the mouth, face, lips, or tongue), contact your doctor immediately. You may need to stop taking Ledifos tablets.
PrecautionsDo not take Ledifos tablets if you are allergic to ledipasvir or sofosbuvir.
Do not take Ledifos tablets if you are already taking another medicine which contains sofosbuvir.
Taking Ledifos tablets in certain scenarios can involve some risk to you, or can prevent if from working as intended. Before beginning treatment, you should tell your doctor if:
you are pregnant, planning to become pregnant, or are breast-feeding
you are currently taking any prescription medicines, or non-prescription medicines (including herbal treatments and dietary supplements)
you have had allergic reactions to medicines, foods, or other substances in the past
you have kidney or liver problems
Some medicines can prevent Ledifos from working properly, or can have there own actions inhibited by Ledifos.
Simeprevir can increase the risk of ledipasvir and sofosbuvir`s side effects
Carbamazepine, oxcarbazepine, phenobarbital, phenytoin, rifabutin, rifampin, rifapentine, St. John`s wort, or tipranavir can decrease the effectiveness of ledipasvir and sofosbuvir
The risk side effects of Digoxin or Rosuvastatin may be increased by the use of ledipasvir and sofosbuvir.
Additional Information:
Product Details:
| Minimum Order Quantity | 1 Bottle |
| Brand | Myhep Lvir By mylan |
| Dosage Form | Tablet |
| Dose/Strength | Ledipasvir 100mg and Sofosbuvir 400mg |
| Packaging Size | 1X28 Tablets |
| Packaging Type | Box |
| Composition | Sofosbuvir and ledipavirTablets |
| Indications | Hepatitis c Treatment |
Since establishment, we have been playing a lead role in offering Myhep Ledipasvir and Sofosbuvir Tablets. These tablets are used for the treatment of chronic hepatitis C (CHC) genotype 1 infection in adults. Our diligent agents source these tablets from the most authentic vendors of the market. The recommended dosages of Myhep Ledipasvir and SofosbuvirTablets is one tablet taken orally once daily with or without food. We offer these tablets at cost effective prices to clients.
Features:
MyHep LVIR is a fixed-dose combination tablet containing ledipasvir and sofosbuvir for oral administration.Each film, coated tablet contains 90 mg ledipasvir and 400 mg sofosbuvir.
INDICATIONS AND USAGE
MyHep LVIR is indicated for the treatment of choronic hepatitis C (CHC) genotype 1 infection in adults.
DOSAGES AND ADMINISTRATION
Recommended Dosage in Adults
MyHepLVIR is two-drug fixed-dose combination product that contained 90 mg of ledipasvir and 400 mg of sofosbuvir in a single tablet.The recommended dosages of MyHepLVIR is one tablet taken orally once daily with or without food.
Duration of treatment
Relapse rates are affected by baseline host and viral factors and differ between treatment durations for certain subgroups. Below provides the recommended LVIR treatment durations for treatment-naive and treatment-experienced patients and those with and without cirrhosis.
DOSAGES FORMS AND STERENGTHS
MyHep LVIR is available as Green colored, oval shaped, film coated tablet debossed with on one side and plain on other side of the tablet.Each tablet contains 90 mg ledipasvir and 400 mg sofosbuvir.
CONTRAINDICATIONS
No contraindications have been identified.
WARNINGS AND PRECAUTIONS
Serious Symptomatic Bradycardia When Coadministered with Amiodarone
Postmarketing cases of symptomatic bradycardia, as well as fetal cardiac arrest and cases requiring pacemaker intervention, have been reported when amiodarone is coadministered with Ledipasvir + Sofosbuvir.Bradycardia has generally occurred within hours to days,btus cases have been observed up to 2 weeks after initiating HCV treatment.Patients also taking beta blockers, or those with underlying cardiac comorbidities and/or advanced liver disease may be at increased risk for symptomatic bradycardia with coadministration of amiodarone.Bradycardia generally resolved after discontinuation of HCV treatment.The mechanism for this effect is unknown.
ADVERSE REACTIONS
Clinical Trials Experience
The most common adverse reactions (>=10%) were fatigue and headache Nausea, Diarrhea, Insomnia in subjects treated with 8, 12, or 24 weeks of Ledipasvir + Sofodbuvir.
Additional Information:
Product Details:
| Minimum Order Quantity | 1 Bottle |
| Brand | Hepcvir |
| Dosage Form | Tablet |
| Dose/Strength | Sofosbuvir 400mg |
| Packaging Size | 1X28 |
| Packaging Type | Strip |
| Composition | Sofosbuvir |
| Indications | Hepatitis c Treatment |
| Form | Tablet |
product
Hepcivir 400mg Tablet containing the active ingredient sofosbuvir is a nucleotide polymerase inhibitor type of antiviral medication used to treat Hepatitis C. Hepcivir Tablets must be used in combination with other antiviral medicines to reduce the amount of hepatitis C virus (HCV) in the body to help the liver recover. Chronic hepatitis C infections can cause serious liver problems such as liver cancer or cirrhosis (scarring). Patients with HIV or liver cancer and are going to have a liver transplant may also use the drug to decrease the risk of reinfection after the transplant.
To satisfying the varied demands of our valuable clients we are highly engaged in offering optimum quality Hepcivir Tablet in the market. Moreover, offered products are available in market in large quantity and clients can buy these products from us within the committed time frame. It is applicable to fight with chronic hepatitis C and can buy the offered range at the reasonably prices with best packaging options.
Side Effects :- Nausea, Diarrhea, Headaches, Loss of appetite, Lower back or side pain, Insomnia,Fever.
Freatures
Additional Information:
Product Details:
| Minimum Order Quantity | 1 Box |
| Type Of Medicines | Life Saving Drug |
| Application | Cure Hepatitis C Virus |
| Dose | 351mg-500mg |
| Brand | Emcure |
| Packaging Type | Box |
| Medicine Type | Life Saving Drug |
| Dosage Form | Tablet |
| Dose/Strength | Sofosbuvir Tablets |
| Indications | Hepatitis C Treatment |
Product Description
We have carved a niche in the market as a prime organization engaged in offering Sofocure Sofosbuvir 400mg Tablets. Our diligent agents procure these tablets from the certified vendors of the market. The tablets are used for the treatment of chronic hepatitis C infection in adults. These are film coated tablets each contain 400mg of the main ingredient. Sofocure Sofosbuvir 400mg Tablets are known as nucleotide polymerase inhibitor and work directly on the virus itself.
Features:
Sofocure 400mg
We Are Counted Among Chief Exporters, Wholesalers, Distributors And Suppliers Of Top Grade Sofocure Medicine. This Medicine Is Widely Used For Treating Chronic Hepatitis C Infection In Adults. Offered Medicine Is Formulated Under The Stern Observation Of Brilliant Experts Using Quality-Approved Sofosbuvir Chemical. Appreciated For Its Instant Results And Accurate Composition, This Medicine Is Highly Demanded In The Market. Further, Provided Sofocure Medicine Can Be Purchased From Us In Packaging Of 28 Tablets Of 400Mg At Reasonable Prices.
Features:
Sofocure 400 Mg Medicine Details –
Warning:Sofocure Is A Prescription Drug And Should Be Used Under Proper Medical Guidance And Advice.The Information Provided Here Is For General Educational Purposes Only And Does Not Constitute Medical Or Pharmaceutical Advice Which Should Be Sought From Qualified Medical And Pharmaceutical Advisers.
Additional Information:
Product Details:
| Minimum Order Quantity | 1 Bottle |
| Dosage Form | Tablet |
| Dose/Strength | 400mg |
| Packaging Size | 28 Tablets |
| Packaging Type | Box |
| Composition | Sofosbuvir Tablets |
| Indications | Treatment for Hepatitis c |
Additional Information:
Product Details:
| Minimum Order Quantity | 1 Bottle |
| Dose/Strength | 90mg 400mg |
| Composition | Ledipasvir And Sofosbuvir |
| Indications | Treatment Of Hepatitis C |
| Packaging Type | Bottle |
| Dosage Form | Tablet |
| Salt | Sofosbuvir, Ladipasvir |
| Type Of Packing | Box Packing |
We have been marked down as a noted organization engaged in offering Ledipasvir and Sofosbuvir Tablets. The tablets are indicated for the treatment of chronic hepatitis C (CHC) genotype 1 infection in adults. Our expert agents procure these tablets from the most authentic vendors of the market. Ledipasvir and Sofosbuvir Tablets contained 90 mg of ledipasvirand 400 mg of sofosbuvir in a single tablet. We offer these tablets at market leading prices to clients.
Features:
Product Description
Hepcinat LP is a fixed-dose combination tablet containing ledipasvir and sofosbuvir for oral administration.Each film, coated tablet contains 90 mg ledipasvir and 400 mg sofosbuvir.
INDICATIONS AND USAGE
Hepcinat LP is indicated for the treatment of choronic hepatitis C (CHC) genotype 1 infection in adults.
DOSAGES AND ADMINISTRATION
Recommended Dosage in Adults
Hepcinat LP is two-drug fixed-dose combination product that contained 90 mg of ledipasvir and 400 mg of sofosbuvir in a single tablet.The recommended dosages of Hepcinat LP is one tablet taken orally once daily with or without food.
Duration of treatment
Relapse rates are affected by baseline host and viral factors and differ between treatment durations for certain subgroups. Below provides the recommended Hepcinat LP treatment durations for treatment-naive and treatment-experienced patients and those with and without cirrhosis.
*Hepcinat LP for 8 weeks can be considered in treatment-naïve patients without cirrhosis who have pre-treatment HCV RNA less than 6 million IU/ mL .
*Treatment-experienced patients who have failed treatment with either peginterferon alfa+ribavirin or an HCV protease inhibitor + peginterferon alfa + ribavirin.
DOSAGES FORMS AND STERENGTHS
Hepcinat LP is available as Green colored, oval shaped, film coated tablet debossed with one side and plain on other side of the tablet.Each tablet contains 90 mg ledipasvir and 400 mg sofosbuvir.
CONTRAINDICATIONS
No contraindications have been identified.
WARNINGS AND PRECAUTIONS
Serious Symptomatic Bradycardia When Coadministered with Amiodarone
Postmarketing cases of symptomatic bradycardia,as well as fetal cardiac arrest and cases requiring pacemaker intervention, have been reported when amiodarone is coadministered with Ledipasvir + Sofosbuvir.Bradycardia has generally occurred within hours to days,btus cases have been observed up to 2 weeks after initiating HCV treatment.Patients also taking beta blockers, or those with underlying cardiac comorbidities and/or advanced liver disease may be at increased risk for symptomatic bradycardia with coadministration of amiodarone.Bradycardia generally resolved after discontinuation of HCV treatment.The mechanism for this effect is unknown.
ADVERSE REACTIONS
Clinical Trials Experience
The most common adverse reactions (>=10%) were fatigue and headache Nausea, Diarrhea, Insomnia in subjects treated with 8, 12, or 24 weeks of Ledipasvir + Sofodbuvir.
Additional Information:
Product Details:
| Minimum Order Quantity | 1 Box |
| Dosage Form | Tablet |
| Dose/Strength | 400mg Sofosbuvir |
| Packaging Size | 28 Tablets |
| Composition | Sofosbuvir |
| Indications | Treatment For Hepatitis C |
| Brand | Sofovir Tablets By Hetero |
| Packaging Type | Box |
| Dosage Form | Tablet |
| Dose/Strength | Sofosbuvir 400mg |
| Packaging Size | 1X7 |
| Composition | Sofosbuvir Tablets |
| Indications | Hepatitis c Treatment |
Product Description
Sofosbuvir tablets are administered orally. Each tablet contains 400 mg of sofosbuvir.
INDICATIONS AND USAGE
Sofosbuvir is indicated in combination with other medical products for the treatment of chronic hepatitis C (CHC) in adults.
DOSAGES AND ADMINISTRATION
Recommended Dose in adults
The recommended dose of sofosbuvir is one 400 mg tablet, taken orally, once daily with or without food sofosbuvir should be used combination with ribavirin or in combination with pegylated interferon and ribavirin for the treatment of CHC in adults.The recommended regimen and treatment duration for the sofosbuvir combination therapy is provided in following table.Dose Modification:
Additional Information:
Product Details:
| Minimum Order Quantity | 1 Bottle |
| Brand | Myhep All By Mylan |
| Dosage Form | Tablet |
| Dose/Strength | Sofosbuvir 400mg And Ledpsavir 100mg |
| Packaging Size | 1X28 |
| Packaging Type | Box |
| Composition | Sofosbuvir And Velpatasvir |
| Indications | Hepatitis c Treatment |
MyLan Pharmaceutical Sofosbuvir and Velpatasvir is used to treat chronic (long-lasting) hepatitis C, a viral infection of the liver. It may sometimes be used with another antiviral medication (ribavirin).
SAFETY INFORMATION (Precautions) for MyHep All SOFOSBUVIR VELPATASVIR TABLETSTo make sure MyHep All is safe for you, tell your doctor if you have:
A history of hepatitis B
Kidney disease (or if you are on dialysis)
Liver problems other than hepatitis
HIV (human immunodeficiency virus) or
If you have recently used a heart rhythm medicine called amiodarone.
It is not known whether MyHep All will harm an unborn baby.
Additional Information:
Product Details:
| Minimum Order Quantity | 1 Bottle |
| Brand | Decihep Tablets By Zydus |
| Dose/Strength | Declatasvir Dihydrochloride Tablets 60mg |
| Packaging Size | 1X28 |
| Packaging Type | Tablets |
| Composition | Declatasvir Dihydrochloride Tablets |
| Indications | Hepatitis c Treament |
Additional Information:
Product Details:
| Minimum Order Quantity | 1 Bottle |
| Brand | Hepcvel By Cipla |
| Dosage Form | Tablet |
| Dose/Strength | Velpatasvir 100mg And Sofosbuvir 400mg |
| Packaging Size | 1X28 Tablets |
| Packaging Type | Box |
| Composition | Velpatasvir And Sofosbuvir |
| Indications | Hepatitis c Treatment |
Hepcvel is used alone or with ribavirin to treat chronic hepatitis C. Sofosbuvir is in a class of antiviral medications called nucleotide hepatitis C virus (HCV) NS5B polymerase inhibitors. Velpatasvir is in a class of antiviral medications called HCV NS5A replication complex inhibitors.
The combination of sofosbuvir and velpatasvir works by stopping the virus that causes hepatitis C from spreading inside the body.
headache;
tired feeling;
nausea, diarrhea; or
sleep problems (insomnia).
slow heartbeats;
weak or shallow breathing; or
low red blood cells-pale skin, weakness, rapid heart rate, trouble concentrating.
If you also take Amiodarone: Get medical help now if you feel weak, tired, or light-headed, or if you have chest pain, shortness of breath, confusion, or memory problems.
This is not a complete list of side effects and others may occur.
Precautions
To make sure Hepcvel is safe for you, tell your doctor if you have:
a history of hepatitis B;
kidney disease (or if you are on dialysis);
liver problems other than hepatitis;
HIV (human immunodeficiency virus); or
if you have recently used a heart rhythm medicine called amiodarone.
It is not known whether Velpanat will harm an unborn baby.
Price of Sofosbuvir 400mg & Velpatasvir 100 mg in India at Chawla Medicos. For more details call or contact us.
Additional Information:
Product Details:
| Minimum Order Quantity | 1 Bottle |
| Brand | Resof Total By Dr. Reddy |
| Dosage Form | Tablet |
| Dose/Strength | Velpatasvir 100mg And Sofosbuvir 400mg |
| Packaging Size | 1X28 |
| Packaging Type | Box |
| Composition | Velpatasvir And Sofosbuvir |
| Indications | Hepatitis c Treatment |
Chronic hepatitis C infection can cause serious liver problems such as scarring (cirrhosis), or liver cancer.The combination of Resof Total works by stopping the virus that causes hepatitis C from spreading inside the body.
MEDICINE USES :Dr. Reddy’s Laboratories Limited Sofosbuvir and Velpatasvir is used to treat chronic (long-lasting) hepatitis C, a viral infection of the liver. It may sometimes be used with another antiviral medication (ribavirin).
Indication :Resof Total ( Sofosbuvir 400 mg & velpatasvir 100 mg) is used alone or with ribavirin to treat chronic hepatitis C. Sofosbuvir is in a class of antiviral medications called nucleotide hepatitis C virus (HCV) NS5B polymerase inhibitors. Velpatasvir is in a class of antiviral medications called HCV NS5A replication complex inhibitors.
The combination of Resof Total works by stopping the virus that causes hepatitis C from spreading inside the body.
Price of Resof Total in IndiaWe assurance of quality and distribution anywhere in the world as per the buyer’s requirements.
Buy Resof Total OnlineWe are not online Pharmacy, Resof Total is a prescription medication pharmaceutical drug that legally requires a medical prescription to be dispensed.
Please contact us for more Details, On How To Buy this Resof Total on Valid Prescription and On availability in Delhi & all over India.
Resof Total is a prescription drug that can be purchased by a patient only against a valid prescription of a healthcare professional like Gastroenterologist, Hepatologist or a Physician.
Common side effects may include:
A headache, Tired Feeling, Nausea, Diarrhea or Sleep Problems (Insomnia).
Call your doctor at once if you have:
Slow Heartbeats, Weak or Shallow Breathing; or low red blood cells-pale skin, weakness, rapid heart rate and trouble concentrating.
If you also take amiodarone: Seek medical help right away if you feel weak, tired, or light-headed, or if you have chest pain, shortness of breath, confusion, or memory problems.
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects.
Additional Information:
Product Details:
| Minimum Order Quantity | 1 Box |
| Brand | Velpaclear Tablets |
| Dosage Form | Tablet |
| Dose/Strength | Sofosbuvir 400mg And Velpatasvir 100mg |
| Packaging Size | 28 Tablets |
| Packaging Type | Bottle |
| Composition | Sofosbuvir And Velpatasvir |
| Indications | The Hepatitis C Treatment Drug |
Marketed By: "Abbott" ;
Indian Brand - "Velpaclear" ;
Active Ingredient(s) - "Sofosbuvir And Velpatasvir" ;
Strength - "400mg And 100mg" ;
Dosage Form - "Tablet" ;
Package Size - "28 Tabs" ;
Package Type - "Plastic Bottle" ;
Expiry - "1 Year to 2 Years" ;
Indication(s) - "Hepatitis C Virus (HCV) Infection" ;
UPC / GTIN Barcode - "No" ;
Prescription Required - "Yes" ;
"The Hepatitis C Treatment Drug"
Velpaclear Is Use For The Treatment Of Hepatitis C Virus. Sofosbuvir And Velpatasvir, sold under the brand name Velpaclear among others. Each tablet contains Sofosbuvir 400 Mg and Velpatasvir 100 mg. It is only recommended with some combination of ribavirin, ledipasvir, Velpatasvir or daclatasvir. Velpatasvir is an NS5A inhibitor which is used together with sofosbuvir in the treatment of hepatitis C infection of all six major genotypes.
Feature:
We are the reliable organization engaged in offering high quality and well-tested Vepaclear Tablets. The offered tablets are appreciated for their purity, effectiveness and long shelf life. Our provided tablets are processed using optimum quality chemical compounds and ultra-modern technology in compliance with industry norms. Apart from this, these tablets are checked by quality analyst against various parameters so as to ensure their quality.
Additional Information:
Product Details:
| Minimum Order Quantity | 1 Bottle |
| Composition | Sofosbuvir And Ledipasvir |
| Indications | The Hepatitis C Treatment Drug |
| Dosage Form | Tablet |
| Brand | Ledviclear Tablets |
| Dose/Strength | Sofosbuvir 400mg And Ledipasvir 90mg |
| Packaging Size | 28Tab |
| Packaging Type | Box |
| Drug Name | Ledviclear Tablets |
| Active Ingredient | Sofosbuvir And Ledipasvir |
Marketed By: "Abbott" ;
Indian Brand - "Ledviclear" ;
Active Ingredient(s) - "Sofosbuvir And Ledipasvir" ;
Strength - "400mg And 90mg" ;
Dosage Form - "Tablet" ;
Package Size - "28 Tabs" ;
Package Type - "Plastic Bottle" ;
Expiry - "1 Year to 2 Years" ;
Indication(s) - "Hepatitis C Virus (HCV) Infection" ;
UPC / GTIN Barcode - "No" ;
Prescription Required - "Yes" ;
"The Hepatitis C Treatment Drug"
Ledviclear 90mg/400mg Tablet is a combination of two antiviral medicines: Ledipasvir and Sofosbuvir.
Ledipasvir and sofosbuvir are antiviral medications that prevent hepatitis C virus (HCV) from multiplying in your body.Ledviclear is used to treat chronic (long-lasting) hepatitis C, a viral infection of the liver. Each Tablet Of Ledviclear Is Contain 90mg Of Ledipasvir And 400mg Of Sofosbuvir.
Side Effects:
When Used In Combination With Peginterferon Alfa/Ribavirin Or Ribavirin Alone, All Contraindications To Peginterferon Alfa And/Or Ribavirin Also Apply To Ledipasvir/Sofosbuvir Combination Therapy.
We are the reliable organization engaged in offering high quality and well-tested Vepaclear Tablets. The offered tablets are appreciated for their purity, effectiveness and long shelf life. Our provided tablets are processed using optimum quality chemical compounds and ultra-modern technology in compliance with industry norms. Apart from this, these tablets are checked by quality analyst against various parameters so as to ensure their quality.
Additional Information:
Product Details:
| Minimum Order Quantity | 1 Bottle |
| Brand | Abbott |
| Dosage Form | Tablet |
| Dose/Strength | Sofosbuvir 400mg |
| Packaging Size | 28 Tablets |
| Packaging Type | Box |
| Composition | Sofosbuvir |
| Indications | The Hepatitis Treatment Drug |
| Drug Name | Viroclear By Abbot |
| Active Ingredient | Sofosbuvir |
Marketed By: "Abbott"
Indian Brand - "Viroclear"
Active Ingredient(s) - "Sofosbuvir"
Strength - "400mg"
Dosage Form - "Tablet"
Package Size - "28 Tabs"
Package Type - "Plastic Bottle"
Expiry - "1 Year to 2 Years"
Indication(s) - "Hepatitis C Virus (HCV) Infection"
UPC / GTIN Barcode - "No"
Prescription Required - "Yes"
"The Hepatitis C Treatment Drug"
Viroclear 400mg Tablet is used in the treatment of chronic hepatitis C virus (HCV) infection. This drug is a prescription drug. It’s available as an oral tablet. This medicine minimizes the chance of recurrence of the infection after the transplantation.
Viroclear Tablet contains Sofosbuvir as an active ingredient.
Feature:
Perfectly formulated
Reliable
Zero side effect
Common Side Effects:
Tiredness,
headache,
nausea,
diarrhea,
Difficulty Sleeping &,
Low Red Blood Cell Count.
difficulty sleeping,
or irritability may occur.
We are the reliable organization engaged in offering high quality and well-tested Viroclear Tablets. The offered tablets are appreciated for their purity, effectiveness and long shelf life. Our provided tablets are processed using optimum quality chemical compounds and ultra-modern technology in compliance with industry norms. Apart from this, these tablets are checked by quality analyst against various parameters so as to ensure their quality.
Additional Information:
Product Details:
| Minimum Order Quantity | 1 Bottle |
| Brand | Ledikast Tablets |
| Dosage Form | Tablet |
| Dose/Strength | Ledipasvir 90mg And Sofosbuvir 400mg |
| Packaging Size | 28 Tablets |
| Packaging Type | Bottle |
| Composition | Ledipasvir and sofosbuvir |
| Indications | The Hepatitis C Treatment Drug |
| Uses | The Hepatitis C Treatment Drug |
| Drug Name | Ledikast Tablets |
| Active Ingredient | Ledipasvir 100mg and Sofobuvir 400mg |
Marketed By:"Aprazer ltd"
Indian Brand - "Ledikast Tablets"
Active Ingredient(s) - "Ledipasvir And Sofosbuvir Tablets"
Strength - "90mg and 400mg"
Dosage Form - "Tablets"
Package Type - "Bottle"
Package Size - "28Tablets"
Expiry - "1 Year to 2 Years"
Indication(s) - "Used In The Treatment Of Hepatitis C Virus."
Product Description
We have uniquely positioned ourselves as a dependable firm, engaged in offering Ledipasvir 90 mg and Sofosbuvir 400 mg. These tablets are indicated for the treatment of chronic hepatitis C (CHC) genotype 1 infection in adults. We procure these tablets from the certified vendors of the market. The tablets are packed in moisture proof materials to ensure safe transportation. Chawla Medicos offer Ledipasvir 90 mg and Sofosbuvir 400 mg at affordable prices to clients.
Features:
Product Details:
| Minimum Order Quantity | 1 Bottle |
| Brand | Velakast Tablets |
| Dosage Form | Tablet |
| Dose/Strength | Velpatasvir 100mg And Sofosbuvir 400mg |
| Packaging Size | 28 Tablets |
| Packaging Type | Bottle |
| Composition | velpatasvir and sofosbuvir |
| Indications | The Hepatitis C Treatment Drug |
| Uses | The Hepatitis C Treatment Drug |
Marketed By: "Aprazer ltd" ;
Indian Brand - "VelakastTablets" ;
Active Ingredient(s) - "Sofosbuvir And Velpatasvir Tablets" ;
Strength - "400mg and 100mg" ;
Dosage Form - "Tablets" ;
Package Type - "Bottle" ;
Package Size - "28Tablets" ;
Expiry - "1 Year to 2 Years" ;
Indication(s) - "Used In The Treatment Of HIV." ;
Velpatasvir & Sofosbuvir (Tablet Velakast) by Hetero is a combination of sofosbuvir and velpatasvir and is used to treat chronic (long-lasting) hepatitis C, a viral infection of the liver. It is also used with another antiviral medication (ribavirin). These drugs work by reducing the amount of hepatitis C virus in your body, which helps your immune system fight the infection and may help your liver recover.
Chronic hepatitis C infection can cause serious liver problems such as scarring (cirrhosis), or liver cancer.
Velakast Sofosbuvir 400 mg & Velpatasvir 100 mg Indication :Sofosbuvir 400 mg & velpatasvir 100 mg is used alone or with ribavirin to treat chronic hepatitis C. Sofosbuvir is in a class of antiviral medications called nucleotide hepatitis C virus (HCV) NS5B polymerase inhibitors. Velpatasvir is in a class of antiviral medications called HCV NS5A replication complex inhibitors.
The combination of sofosbuvir and Velpatasvir works by stopping the virus that causes hepatitis C from spreading inside the body.
Product Details:
| Minimum Order Quantity | 1 Bottle |
| Brand | Decikast Tablets |
| Shelf Life | Long Expiry |
| Dose/Strength | Declatasvir 60mg |
| Composition | Daclatasvir |
| Indications | The Hepatitis c Treatment Drug |
| Packaging Size | 1x28 |
| Packaging Type | tablets |
| Drug Name | decikast Tablets |
| Dosage Form | Tablet |
| Active Ingredient | Daclatasvir 60mg |
Marketed Zydus
Indian Brand -DacikastTablets
Active Ingredient(s) -DaclatasvirDiydrochloride Tablets
Strength - 60mg
Dosage Form - Tablet
Package Size - 28 Tabs
Package Type - Plastic Bottle
Expiry - 1 Year to 2 Years
Indication(s) - Hepatitic C Virus (HCV) Infection
UPC / GTIN Barcode - No
Prescription Reqiured - Yes
Note These Tablets is a prescription drug. Do not share the medicine with others, since they may be suffering from a problem that is not effectively treated by this drug.
Minimum Order Quantity 1 Piece(s)
Port of Dispatch New Delhi, India
Production Capacity As per your required
The dosage should be determined by the doctor based on your age, overall medical history and current condition. The usual dose in adults for treating chronic hepatitis C is 60 mg, taken orally once daily for a period of 12 weeks.
Product Details:
| Minimum Order Quantity | 1 Bottle |
| Brand | Hepcinat Plus By Natco |
| Dose/Strength | Sofosbuvir 400mg And Daclatasvir 60mg |
| Composition | Sofosbuvir And Daclatasvir |
| Indications | The Hepatitis C Treatment Drug |
| Application | Hepatitis C |
| Shelf Life | 1 To 2 Year |
| Packaging Size | 1x28 |
| Packaging Type | Tablets |
| Dosage Form | Tablet |
| Uses | The Hepatitis C Treatment Drug |
| Manufactured By | Natco |
| Marketed By | Natco |
Marketed Natco
Indian Brand – Hepcinat Plus Tablets
Active Ingredient(s) – Sofosbuvir And Daclatasvir Diydrochloride Tablets
Strength – 400mg and 60mg
Dosage Form – Tablet
Package Size – 28 Tabs
Package Type – Plastic Bottle
Expiry – 1 Year to 2 Years
Indication(s) – Hepatitic C Virus (HCV) Infection
Note These Tablets is a prescription drug. Do not share the medicine with others, since they may be suffering from a problem that is not effectively treated by this drug.
Minimum Order Quantity 1 Piece(s)
Port of Dispatch New Delhi, India
Production Capacity As per your required
Hepcinat Plus tablet is an antiviral medication. It works by lowering a load of hepatitis C virus in the body and removing the virus from the blood over a period of time. These medications together reduce the amount of hepatitis C virus in your body, which helps your immune system fight the infection and may help your liver recover. Chronic hepatitis C infection can cause serious liver problems such as scarring (cirrhosis), or liver cancer.
The dosage should be determined by the doctor based on your age, overall medical history and current condition. The usual dose in adults for treating chronic hepatitis C is 60 mg, taken orally once daily for a period of 12 weeks.
Additional Information:
Product Details:
| Minimum Order Quantity | 1 Bottle |
| Drug Name | Sovihep D Tablets |
| Brand | Zydus |
| Dose/Strength | Sofosbuvir 400mg And Daclatasvir 60mg |
| Composition | Sofosbuvir And Daclatasvir |
| Indications | Used In The Treatment Of Hepatitis C |
| Manufactured By | Hetero |
| Marketed By | Zydus |
Product Details:
| Minimum Order Quantity | 1 Bottle |
| Dose/Strength | Daclatasvir Tablets 30/60mg |
| Packaging Size | 1X28 |
| Packaging Type | Strip |
| Composition | declatasvir Dihydrochloride Tablets |
| Indications | Hepatitis c Treament |
We are identified as one of the leading organizations, engaged in offering Natdac Tablets. Our expert agents procure these tablets from the certified vendors of the market. The tablets are indicated in combination with sofosbuvir for the treatment of patient with chronic hepatitis C virus. Natdac Daclatasvir Tablets are recommended to be taken orally with or without meals. We offer these tablets at pocket friendly prices.
Features:
Natdac 60 is an inhibitor of non-structural protein 5A (NS5A).
Each film-coated tablet contains Daclatasvir equivalent to Daclatasvir 30 mg or 60 mg.
INDICATIONS AND USAGE
Natdac 60 is indicated in combination with Sofosbuvir for the treatment of patient with chronic hepatitis C virus (HCV) genotype 3 infection.
DOSAGE AND ADMINISTRATION
Treatment with Natdac 60 should be initiated and monitored by physician experienced in the management of chronic hepatitis C. The recommended dose of Natdac 60 is 60 mg once daily to be taken orally with or without meals. MyDacla 60 must be administered in combination with other medical products.The Packeges inserts of the medicinal products in the regimen should also be consulated before initiation of therapy with Natdac 60. Recommended reginmens and treatment duration are provided below.
Dose modification, interruption and discontinuation
Dose modification of Natdac 60 to manage adverse reactions is not recommended.There is no virologic treatment stopping rules that apply to the combination of Natdac 60 with sofosbuvir.
CONTRAINDICATIONS
Hypersensitivity to the active substance or to any of the excipients Coadministration with medicinal products that strongly induce cytochrome P450 3A4 (CYP3A4) and P-glycoprotein transporter (P-gp) and thus may lead to lower exposure and loss of efficacy of Daclatasvir. These active substances include but are not limited to phenytoin, carbamazepine, oxcarbazepine, rifampicin, rifapentine, systemic dexamethasone, and the herbal product St John’s wort (Hypericum perforatum).
WARNINGS AND PRECAUTIONS
Natdac 60 must not be administered as monotherapy.DeciHeptm must be administered in combination with other medicinal products for the the treatment of chronic HCV infection.
General
The safety and efficacy of the combination of Daclatasvir and sofosbuvir have been evaluated in a limited number of patients with cirrhosis in clinical studies.
Decompensates liver disease
The safety and efficacy of MyDacla 60 in the treatment of HCV infection in patients with decompensated liver disease have not been established.
Retreatment with MyDacla 60
The efficacy of MyDacla 60 as part of a retreatment regimen in patients with prior exposure to a NS5A inhibitor has not been established.
Pregnancy and contraception requirements
Natdac 60 should not be used during pregnancy or in women of childbearing potential not using contraception.Use of highly effective contraception should be continued for 5 weeks after completion of Daclatasvir therapy.
ADVERSE REACTIONS
Adverse reactions in clinical trials.
The most common adverse reactions(>=10%) were fatigue and headache, aneamia,hot flush,nausea in subjects treated with 8, 12, or 24 weeks of Ledipasvir + Sofosbuvir.
DRUG INTERACTIONS
Contraindications of concomitant use
Additional Information:
Product Details:
| Minimum Order Quantity | 1 Box |
| Brand | Tenvir Tablets |
| Dose/Strength | Tenofovir Tablets |
| Packaging Size | 1x30 |
| Composition | Tenofovir Tablets |
| Indications | For The Hepatitis B and HIV Infection |
Product Description
These tablets belong to a class of HIV drugs called nucleoside reverse transcriptase inhibitors. Owing to our rich knowledge as well as professional workforce, we have achieved a noted position as a reliable organization engaged in offering Tenofovir Disoproxil Fumarate Tablets. These tablets are used for the treatment of chronic hepatitis B and HIV infection. Our expert agents source these tablets from the trusted and reliable vendors of the market. We offer Tenofovir Disoproxil Fumarate Tablets at affordable prices.
Features:
Tenvir Tenofovir
TENVIR Hepatitis Medicine,Anti Cancer medicine distributor Suppliers Dealers Exporters Distributors Traders Russia, Ukraine, South Korea, Philippines, Delhi India.
Owing to our vast domain knowledge, we have established ourselves as an affluent distributor, wholesaler, trader and supplier of Tenvir Tablets. The offered tablets are used for the treatment of chronic hepatitis B infection. These tablets are precisely processed utilizing fine grade medical grade chemicals according to the defined industry standards. We are providing these Tenvir Tablets in different packaging options to our clients at market leading price.
Additional Information:
Product Details:
| Minimum Order Quantity | 1 Bottle |
| Composition | Sofosbuvir Tablets |
| Indications | Treatment Of Hepatitis C |
| Dose/Strength | Sofosbuvir Tablets 400mg |
| Packaging Size | 1x30 |
| Packaging Type | Tablets |
Hepcinat contain oral nucleotide analog inhibitor of the hepatitis C virus (HCV) polymerase. Chawla Medicos have been setting benchmarks of success in the market as a prominent organization engaged in offering Hepcinat. These are antiviral drug, used in combination with other drugs for treatment of hepatitis C. Our expert agents source Hepcinat tablets from India the trusted and certified vendors of the market. We offer these Hepcinat Tablets at affordable prices to clients.
Features:
Product Description
Hepcinat Tablets (Sofosbuvir 400 mg)-Generic suppliers, distributors in Delhi, India.
Brand Name: Hepcinat Tablets
Generic Name: Sofosbuvir
Strength: 400 mg
Form: Tablets
Trade Name:HEPCINAT 400mg Manufactured By NATCO PHARMA LIMITED
Composition: Each film coated tablet contains: Sofosbuvir equivalent to Sofosbuvir 400 mg.
Sofosbuvir 400mg tablets is an antiviral drug which is used in combination with other drugs for treatment of Hepatitis C Virus (HCV) infection. Compared to previous treatments, sofosbuvir based regimens provide a higher cure rate, fewer side effects, and a two- to four-fold reduced duration of therapy.
Mechanism of Action:- Sofosbuvir contains oral nucleotide analog inhibitor of the hepatitis C virus (HCV) polymerase. The drug is a direct-acting antiviral agent and interferes straight with the HCV lifecycle, restraining the viral replication. It can be incorporated into HCV RNA by the NS5B polymerase and acts as a chain terminator. The drug is available for oral use in the form of HEPCINAT 400mg tablets.
Dosage and Administration: The recommended daily dose of Sofosbuvir is 400 mg tablet to be taken once daily with or without food. Sofosbuvir should be used in combination with Ribavirin or in combination with Pegylated Interferon and Ribavirin for the treatment of CHC (Chronic Hepatitis C) in adults. It is highly advisable to administer the drug under strict medical supervision and advice.
Side Effects:
Adverse events associated with the use of Sofosbuvir in combination with Ribavirin may include but are not limited to, the following
Adverse events associated with the use of Sofosbuvir in combination with Peginterferon Alfa and Ribavirin may include, but are not limited to, the following:
Packaging: Each Bottle contains 28 tablets of Sofosbuvir 400 mg.
Storage: Store at 25°C in a dry place.
Additional Information:
Product Details:
| Minimum Order Quantity | 1 Bottle |
| Brand | Sofocure By Emcure |
| Dosage Form | Tablet |
| Dose/Strength | sofosbuvir 400mg |
| Packaging Size | 1X28 |
| Packaging Type | Strip |
| Composition | Sofosbuvir Tablets |
| Indications | Hepatitis c Treatment |
Specifications:
Product Description
We have carved a niche in the market as a prime organization engaged in offering Sofocure Sofosbuvir 400mg Tablets. Our diligent agents procure these tablets from the certified vendors of the market. The tablets are used for the treatment of chronic hepatitis C infection in adults. These are film coated tablets each contain 400mg of the main ingredient. Sofocure Sofosbuvir 400mg Tablets are known as nucleotide polymerase inhibitor and work directly on the virus itself.
Features:
Sofocure 400mg
We Are Counted Among Chief Exporters, Wholesalers, Distributors And Suppliers Of Top Grade Sofocure Medicine. This Medicine Is Widely Used For Treating Chronic Hepatitis C Infection In Adults. Offered Medicine Is Formulated Under The Stern Observation Of Brilliant Experts Using Quality-Approved Sofosbuvir Chemical. Appreciated For Its Instant Results And Accurate Composition, This Medicine Is Highly Demanded In The Market. Further, Provided Sofocure Medicine Can Be Purchased From Us In Packaging Of 28 Tablets Of 400Mg At Reasonable Prices.
Features:
Sofocure 400 Mg Medicine Details –
Warning:Sofocure Is A Prescription Drug And Should Be Used Under Proper Medical Guidance And Advice.The Information Provided Here Is For General Educational Purposes Only And Does Not Constitute Medical Or Pharmaceutical Advice Which Should Be Sought From Qualified Medical And Pharmaceutical Advisers.
Additional Information:
Product Details:
| Minimum Order Quantity | 1 Bottle |
| Brand | Virso Tablets By Strides |
| Dosage Form | Tablet |
| Dose/Strength | Sofosbuvir 400mg |
| Packaging Size | 1X28 Tablets |
| Packaging Type | Box |
| Composition | Sofosbuvir Tablets |
| Indications | Hepatitis c Treatment |
Virso 400mg Tab 28s Salt Information :
Uses of Virso 400mg Tab 28s:
Sofosbuvir is a prescription medicine used with other antiviral medicines to treat chronic (lasting a long time) hepatitis C (Hep C) infection in adults.
Side Effects of Virso 400mg Tab 28s:
For Sofosbuvir used in combination with ribavirin they include tiredness and headache and for Sofosbuvir used in combination with peginterferon alfa and ribavirin they include the additional side effects of nausea, difficulty sleeping, and low red blood cell count.
Drug Interactions of Virso 400mg Tab 28s:
If you have: liver problems other than hepatitis C infection; had a liver transplant; severe kidney problems or are on dialysis; HIV; any other medical condition; or if you are breastfeeding or plan to breastfeed. You and your healthcare provider should decide if you will take Sofosbuvir or breastfeed. You should not do both. If you take amiodarone Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Other medicines may affect how Sofosbuvir works.
Contraindications of Virso 400mg Tab 28s:
When used in combination with peginterferon alfa/ribavirin or ribavirin alone, all contraindications to peginterferon alfa and/or ribavirin also apply to Sofosbuvir combination therapy.
Mechanism of Action of Virso 400mg Tab 28s:
Sofosbuvir inhibits the RNA polymerase that the hepatitis C virus uses to replicate its RNA. It was discovered at Pharmasset and developed by Sciences.
Special Precautions for Virso 400mg Tab 28s:
Bradycardia with amiodarone coadministration: Serious symptomatic bradycardia may occur in patients taking amiodarone and Sofosbuvir in combination with another direct acting antiviral (DAA), particularly in patients also receiving beta blockers, or those with underlying cardiac comorbidities and/or advanced liver disease. Coadministration of amiodarone with Sofosbuvir in combination with another DAA is not recommended. In patients without alternative, viable treatment options, cardiac monitoring is recommended. Pregnancy: Ribavirin may cause birth defects and fetal death and animal studies have shown interferons have abortifacient effects; avoid pregnancy in female patients and female partners of male patients. Patients must have a negative pregnancy test prior to initiating therapy, use at least 2 effective methods of contraception and have monthly pregnancy tests.
Additional Information:
Product Details:
| Minimum Order Quantity | 1 Box |
| Brand | Biocon |
| Packaging Size | 1X28 |
| Composition | Daclatasvir 60mg |
| Indications | Cure The Hepatitis C Tablets |
Description:
Daclatasvir is used with another antiviral medication (sofosbuvir) to treat chronic (long-lasting) hepatitis C, a viral infection of the liver. Daclatasvir should never be used without sofosbuvir. Daclatasvir and sofosbuvir may also be used with another antiviral medication (ribavirin). These medications together reduce the amount of hepatitis C virus in your body, which helps your immune system fight the infection and may help your liver recover. Chronic hepatitis C infection can cause serious liver problems such as scarring (cirrhosis), or liver cancer.
Dosage and Administration:
Take daclatasvir exactly as your healthcare provider tells you to.
The recommended usage of daclatasvir to treat chronic hepatitis C virus is 60 mg taken orally once daily with or without food in combination with sofosbuvir. The recommended treatment duration is 12 weeks.
Additional Information:
Product Details:
| Minimum Order Quantity | 1 Box |
| Brand | Cipla |
| Packaging Size | 1X28 |
| Composition | Daclatasvir Tablets |
| Indications | Cure The Hepatitis C Virus |
Marketed: Cipla
Hepcdac is used with another antiviral medication (sofosbuvir) to treat chronic (long-lasting) hepatitis C, a viral infection of the liver. These medications together reduce the amount of hepatitis C virus in your body, which helps your immune system fight the infection and may help your liver recover. Chronic hepatitis C infection can cause serious liver problems such as scarring (cirrhosis), or liver cancer.
On using this medication you may experience side effects such as nausea, headache, weakness, fatigue, breakdown of the red cell, diarrhoea, drowsiness, dizziness and skin rash. If your reactions persist or become worse over time seek the help of your health care provider right away.
The dosage should be determined by the doctor based on your age, overall medical history and current condition. The usual dose in adults for treating chronic hepatitis C is 60 mg, taken orally once daily for a period of 12 weeks.
Additional Information:
Product Details:
| Minimum Order Quantity | 1 Bottle |
| Brand | Chawla Medicos |
| Dosage Form | Tablet |
| Packaging Type | Bottle |
Product Details:
Strength/Dose (in mg or ml)sofosbuvir 400 mg and velpatasvir 100 mgPack Size28 TabProduct TypeFinish Product
Indication:
Sofosbuvir With Velpatasvir is a two-drug combination for the treatment of hepatitis C. It is administered as a single daily pill containing the viral NS5A inhibitor velpatasvir and sofosbuvir, a nucleotide inhibitor of the viral RNA polymerase. It is the first treatment, that works for all genotypic, and is taken entirely by mouth. A single tablet regimen is used for adults with genotype 1-6 chronic hepatitis C virus (HCV) infection.
Mechanism of action:
Sofosbuvir With Velpatasvir is an oral fixed-dose combination of sofosbuvir, a nucleotide analog NS5B polymerase inhibitor and velapatasvir, an NS5A complex inhibitor. Sofosbuvir is approved for the treatment of genotype 1, 2, 3 and 4 HCV infection with different regimens and durations dependent on the HCV genotype. Velpatasvir (formerly GS-5816) is a novel NS5A inhibitor that has potent invitro anti-HCV activity across all genotypes at the picomolar level. The combination of sofosbuvir-velpatasvir is the first once-daily single-tablet regimen with pangenotypic activity.
Dosage and Administration:
Sofosbuvir With Velpatasvir is available as a coformulated, once-daily single-pill combination of sofosbuvir 400 mg and velpatasvir 100 mg. The recommended dose is one tablet once daily, taken with or without food.
Renal Impairment: For patients with mild to moderate renal impairment, no dosage adjustment of sofosbuvir-velpatasvir is recommended. There are insufficient data regarding the safety and efficacy of sofosbuvir-velpatasvir in patients with severe renal impairment (eGFR less than 30 ml/min/1.73m2) or end-stage renal disease requiring hemodialysis. Accordingly, no dosage recommendation has been given for patients with severe renal impairment or end-stage renal disease requiring dialysis.
Hepatic Impairment: For patients with mild, moderate, or severe hepatic impairment (Child-Pugh Class A, B, or C), no dosage adjustment for sofosbuvir-velpatasvir is recommended. For patients with decompensated cirrhosis who are receiving sofosbuvir-velpatasvir and ribavirin, clinical and laboratory monitoring is recommended.
Precaution:
Risk of Serious Symptomatic Bradycardia When Sofosbuvir Is Coadministered with Amiodarone and Another HCV Direct Acting Antiviral: Amiodarone is not recommended for use with Sofosbuvir With Velpatasvir due to the risk of symptomatic bradycardia, particularly in patients also taking beta blockers or with underlying cardiac comorbidities and/or with advanced liver disease. In patients without alternative, viable treatment options, cardiac monitoring is recommended. Patients should seek immediate medical evaluation if they develop signs or symptoms of bradycardia.
Risk of Reduced Therapeutic Effect Due to Concomitant Use of Sofosbuvir With Velpatasvir with P-gp Inducers and/or Moderate to Potent Inducers of CYP2B6, CYP2C8 or CYP3A4: Rifampin, St. John’s wort, and carbamazepine are not recommended for use with Sofosbuvir With Velpatasvir as they may significantly decrease sofosbuvir and/or velpatasvir plasma concentrations.
Product Details:
| Minimum Order Quantity | 1 Bottle |
| Packaging Size | 1x10, 1x20, 1x30 |
| Packaging Type | Botle |
Product Details:
| Brand | Chawla Medicos |
| Dosage Form | Tablet |
| Packaging Type | Bottle |
Product Details:
| Minimum Order Quantity | 1 Bottle |
| Brand | Chawla Medicos |
| Dosage Form | Tablet |
| Packaging Type | Bottle |
Brand: Velasof
Pack Size: 28 Tabs
Product Type: Finish Product
Strength/Dose (in mg or ml): Sofosbuvir 400mg Ledipasvir
Product Details:
| Minimum Order Quantity | 1 Piece |
| Dosage Form | Tablet |
| Brand | Myhep all |
| Packaging Size | 28 tablets |
Product Details:
| Minimum Order Quantity | 1 Bottle |
| Form | Tablet |
| Dose | 400mg |
| Medicine type | Allopathic |
| Dosage Form | Tablet |